Related Experiment Video
Updated: Jun 23, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Treatment of the elderly hypertensive: a clinical perspective
W H Birkenhäger1, P W de Leeuw
1Zuiderziekenhuis, Department of Internal Medicine, Rotterdam, The Netherlands.
Insights
Antihypertensive treatment significantly benefits elderly individuals with high blood pressure, improving cardiovascular prognosis. Thiazide diuretics are recommended as the first-choice treatment for elderly hypertension based on trial results.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- High blood pressure (hypertension) poses significant risks to elderly health and longevity.
- Physicians often hesitate to treat hypertension in older adults due to concerns about cardiovascular homeostasis.
- Recent trials indicate a positive benefit-to-risk ratio for antihypertensive therapy in the elderly.
Purpose of the Study:
- To review evidence on the efficacy and safety of antihypertensive treatments in elderly patients.
- To present findings from the European Working Party on Hypertension in the Elderly (EWPHE) trial.
- To provide practice recommendations for managing hypertension in older adults.
Main Methods:
- Review of controlled trials on antihypertensive treatment in elderly hypertensives.
- Detailed analysis of the European Working Party on Hypertension in the Elderly (EWPHE) trial data.
- Consideration of different classes of hypotensive drugs and their implications.
Main Results:
- Multiple controlled trials demonstrate favorable outcomes for antihypertensive treatment in elderly individuals.
- The EWPHE trial provides extensive data supporting treatment benefits.
- Thiazides, with potassium-sparing agents, emerge as a recommended first-line therapy despite biochemical considerations.
Conclusions:
- Antihypertensive treatment is beneficial for cardiovascular prognosis in elderly patients with hypertension.
- Thiazides are recommended as the initial treatment of choice for elderly hypertension.
- Further research is needed to clarify the roles of other drug classes like beta-blockers, calcium channel blockers, and ACE inhibitors.
Abstract:
The negative effects of high blood pressure on longevity and health in the elderly are considerable. Despite this fact physicians still tend to be reluctant when it comes to exposing elderly hypertensives to antihypertensive treatment. To some extent this cautious attitude can be rationalized because cardiovascular homeostasis becomes less effective with increasing age, particularly in hypertension. Over the past decade, however, several controlled trials have demonstrated a favourable benefit/hazard ratio with respect to the effects of antihypertensive treatment on cardiovascular prognosis in elderly hypertensives. The results of these trials are briefly reviewed, followed by a more extensive report on the trial conducted by the European Working Party on Hypertension in the Elderly (EWPHE). The implications for practice are considered with respect to different classes of hypotensive drugs. Thiazides--with potassium sparing adjuvants--despite their biochemically untoward effects are recommended as the treatment of first choice in view of the trial results. The remainder (beta-blockers, calcium channel blockers, ACE inhibitors, ketanserin) are still in the competing stage, although there may be clarification in the near future in terms of subjective side-effects and ancillary properties.
Related Concept Videos
Drug Dosing: Geriatric Patients
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

